Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
Article in The Lancet (March 2024)
The most recent citing publications are shown below. View all 115 publications that cite this research output on Dimensions.
Article in The Lancet (March 2024)
Article in Ophthalmic Surgery Lasers and Imaging Retina (February 2024)
Article in Retina (February 2024)